News
News
- Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
12/18/2020 / 22:49 - GlobeNewswire - CLAYTON & LITTLE IS NOW CLAYTON KORTE
12/17/2020 / 23:06 - GlobeNewswire - miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
12/17/2020 / 13:00 - GlobeNewswire - Nasdaq closes at all-time high after Fed's decision
12/16/2020 / 22:00 - TeleTrader - Swiss Brand On's New Flagship Store Experience Ushers In The Future of Retail
12/16/2020 / 06:00 - GlobeNewswire - Zealand Pharma announces data from the first phase 3-trial with dasiglucagon in Congenital Hyperinsulinism (CHI)
12/15/2020 / 14:21 - GlobeNewswire - Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001
12/15/2020 / 14:00 - GlobeNewswire - MediciNova Added to the NASDAQ Biotechnology Index
12/15/2020 / 12:30 - GlobeNewswire - Vista Gold Drilling Confirms Adjacent Mineralized Zone at the Mt Todd Gold Project
12/14/2020 / 23:12 - GlobeNewswire - Peloton, Marvell added to Nasdaq 100 index
12/14/2020 / 14:45 - TeleTrader
Real-time